Happy holidays from Med Communications
The entire team at Med Communications would like to wish our clients, prospects, colleagues, and friends a safe, restful, and joyous holiday and a bright 2025.
The entire team at Med Communications would like to wish our clients, prospects, colleagues, and friends a safe, restful, and joyous holiday and a bright 2025.
Our highly skilled Scientific Communications team of healthcare professionals leveraged their collected knowledge to meet our client’s unique standard response and literature database needs. Our newest case study focuses on…
Med Communications’ expertise in implementing and managing reference libraries helped a client increase efficiency, which resulted in overall cost savings. A pharma client needed Med Communications’ support to implement a…
In the Med Affairs world, the identification, tiering, and mapping of Key Opinion Leaders (KOLs), also known as Key External Experts (KEEs), is a critical initial step in the dissemination…
A pharmacovigilance (PV) system covering all PV activities is required of all marketing authorization holders. This system must include the activities of collection and processing of safety information, reporting to…
Med Communications has benefited from the extensive skills, knowledge, and insights of Business Development Lead Jill Kembel, PharmD, for nearly a decade. Jill has more than 20 years’ experience in…
Every clinical trial requires safety monitoring and management, beginning early in the product development life cycle. The data obtained during safety monitoring help with product safety profile classification and also…
As our American colleagues and clients prepare to celebrate Thanksgiving this Thursday, we wanted to give thanks to each of you. We appreciate your trust and your support — we…
Promotional review is traditionally accomplished by groups of professionals who meet a few times per week to review assets. It generally takes several weeks to approve an asset, and sometimes…
AMCP formulary dossiers offer a comprehensive view of the US clinical, safety, and economic evidence for new and existing medical drugs, tests, and devices, helping health care decision makers make…